Are quantitative functional measures more sensitive to worsening MS than traditional measures?

Neurology

Volumn 55, Issue 12, 2000, Pages 1901-1903

  Schwid, Steven R ^a,f   Goodman, A D ^a   Apatoff, B R ^b   Coyle, P K ^c   Jacobs, L D ^d   Krupp, L B ^c   Miller, A E ^e   Wende, K E ^d   Brownscheidle, C M ^d  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e MAIMONIDES MEDICAL CENTER   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN FUNCTION; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MOBILIZATION; MULTIPLE SCLEROSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELIABILITY;

EID: 0034719090     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.12.1901     Document Type: Article

References (10)

1. Outcomes comes assessment in multiple sclerosis clinical trials: A critical analysis
2. The measurement of ambulatory function in multiple sclerosis
3. Clinical outcomes assessment in multiple sclerosis
4. Recommendations form the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force
5. Development of a multiple sclerosis functional composite as a clinical trial outcome measure
6. Linomide in relapsing and secondary progressive multiple sclerosis. I. Trial design and clinical results
7. Linomide in relapsing and secondary progressive multiple sclerosis. II. MRI results
8. A profile of multiple sclerosis: The New York State Multiple Slerosis Consortium
9. Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS)
10. Comparing the ability of various compositive outcomes of discriminate treatment effects in MS clinical trials